FARYDAK
Live / Registered — Registered — Section 71 accepted (as of 23 Jul 2018)
What this means for you
Registered since 16 Sept 2008. The owner can stop confusingly similar uses in the classes it covers; it stays on the register as long as the owner keeps up the maintenance filings (next due by 16 Sept 2028: the §71 ten-year affidavit of use).
Record
- Serial number
- 79050673
- Registration number
- 3502071
- Mark type
- Word mark
- Filed
- 01 Feb 2008
- Published for opposition
- 01 Jul 2008
- Registered
- 16 Sept 2008
- Next maintenance filing
- §71 ten-year affidavit of use, due by 16 Sept 2028 (grace period to 16 Mar 2029)
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical preparations for use in oncology
Owner
- pharma& Schweiz GmbH, CH
- Secura Bio, Inc., US
- Novartis AG, CH
- NOVARTIS AG, CH-4002 Basel, CH
- NOVARTIS AG, CH-4002 Basel, CH
Prosecution history
- 20 Oct 2023 — LIMITATION FROM THE IB EXAMINED, NO ACTION IS NEEDED
- 24 Jul 2023 — RESTRICTION OF HOLDER'S RIGHT OF DISPOSAL RECEIVED
- 19 Feb 2023 — CHANGE OF OWNER RECEIVED FROM IB
- 27 Oct 2020 — APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
- 27 Oct 2020 — TEAS CHANGE OF CORRESPONDENCE RECEIVED
- 27 Oct 2020 — ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
- 27 Oct 2020 — TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
- 27 Oct 2020 — TEAS CHANGE OF OWNER ADDRESS RECEIVED
- 08 Aug 2019 — CHANGE OF OWNER RECEIVED FROM IB
- 23 Jul 2018 — NOTICE OF ACCEPTANCE OF SEC. 71 - E-MAILED
- 23 Jul 2018 — REGISTERED-SEC.71 ACCEPTED
- 13 Jul 2018 — TEAS SECTION 71 RECEIVED
- 15 Feb 2018 — INTERNATIONAL REGISTRATION RENEWED
- 16 Sept 2017 — COURTESY REMINDER - SEC. 71 (10-YR) E-MAILED
- 15 Mar 2015 — NOTICE OF ACCEPTANCE OF SEC. 71 - E-MAILED